1. EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro
- Author
-
Jin I. Lee, Rackhyun Park, Yea-In Park, Yeo-Eun Cha, Minsu Jang, Junsoo Park, and Ayane Yamamoto
- Subjects
0301 basic medicine ,HCoV-OC43 ,3CL-protease ,COVID-19, the 2019 novel coronavirus disease ,viruses ,EGCG, (−)-epigallocatechin-3-gallate ,Biophysics ,Alpha (ethology) ,medicine.disease_cause ,Virus Replication ,Biochemistry ,complex mixtures ,SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 ,Article ,Coronavirus OC43, Human ,03 medical and health sciences ,0302 clinical medicine ,Coronavirus 229E, Human ,Cell Line, Tumor ,medicine ,Humans ,Amino Acid Sequence ,Cytotoxicity ,Molecular Biology ,Coronavirus 3C Proteases ,Coronavirus ,Tea ,Chemistry ,SARS-CoV-2 ,RNA ,Polyphenols ,food and beverages ,virus diseases ,HCoV-229E ,Cell Biology ,3CL-protease, 3C-Like protease ,Green tea ,Human coronavirus ,Virology ,In vitro ,030104 developmental biology ,Polyphenol ,030220 oncology & carcinogenesis ,sense organs ,EGCG - Abstract
COVID-19 pandemic results in record high deaths in many countries. Although a vaccine for SARS-CoV-2 is now available, effective antiviral drugs to treat coronavirus diseases are not available yet. Recently, EGCG, a green tea polyphenol, was reported to inhibit SARS-CoV-2 3CL-protease, however the effect of EGCG on coronavirus replication is unknown. In this report, human coronavirus HCoV-OC43 (beta coronavirus) and HCoV-229E (alpha coronavirus) were used to examine the effect of EGCG on coronavirus. EGCG treatment decreases 3CL-protease activity of HCoV-OC43 and HCoV-229E. Moreover, EGCG treatment decreased HCoV-OC43-induced cytotoxicity. Finally, we found that EGCG treatment decreased the levels of coronavirus RNA and protein in infected cell media. These results indicate that EGCG inhibits coronavirus replication., Graphical abstract Image 1
- Published
- 2021